|
|
|
 |
 |
|
       |
|
|
|
News | News Archives  December 10, 2001 Protein Sciences Corporation (PSC) announced today that it has signed a contract with the National Institute of Allergy and Infections Diseases (NIAID) that provides for up to $76 million in funding through mid-2006 for development and production of antigens for new vaccines for HIV/AIDS. November 27, 2001 Protein Sciences Corporation (PSC) announced today that it has reacquired all rights to two patented, late stage influenza vaccines. November 12, 2001 Protein Sciences Corporation (PSC) announced today the closing of a financing of more than $2 million in new equity and restructuring of its balance sheet to eliminate all $27 million in debt, security interests and preferences. Investors include existing and new investors. October 16, 2000 Northwest Biotherapeutics, Inc. announced today that it has selected Protein Sciences Corporation, Meriden, Connecticut to develop a high yield expression vector for production of a proprietary kidney cancer-specific protein as a component of a new treatment for renal cell carcinoma. The terms of the agreement were not disclosed. November 30, 2000 Protein Sciences Corporation (PSC) and HTS Biosystems, Inc. (HTS), announced today that they have entered into a strategic collaboration to facilitate the discovery of novel protein molecules for the drug and diagnostics markets through innovative solutions for proteomics. June 6, 2000 Protein Sciences Corporation (PSC) and Nihon Nosan Kogyo KK (NNK) are pleased to announce today that they have entered into a distribution agreement to market PSC's research products in Japan. |
|
|
|
||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
